Skip to main content
Top
Published in: Diabetologia 12/2008

01-12-2008 | Article

Lifetime risk and projected population prevalence of diabetes

Authors: D. J. Magliano, J. E. Shaw, S. M. Shortreed, W. J. Nusselder, D. Liew, E. L. M. Barr, P. Z. Zimmet, A. Peeters

Published in: Diabetologia | Issue 12/2008

Login to get access

Abstract

Aims/hypothesis

With incidence rates for diabetes increasing rapidly worldwide, estimates of the magnitude of the impact on population health are required. We aimed to estimate the lifetime risk of diabetes, the number of years lived free of, and the number of years lived with diabetes for the Australian adult population from the year 2000, and to project prevalence of diabetes to the year 2025.

Methods

Multi-state life-tables were constructed to simulate the progress of a cohort of 25-year-old Australians. National mortality rates were combined with incidence rates of diabetes and the RR of mortality in people with diabetes derived from the Australian Diabetes, Obesity and Lifestyle study (a national, population-based study of 11,247 adults aged ≥25 years).

Results

If the rates of mortality and diabetes incidence observed over the period 2000–2005 continue, 38.0% (95% uncertainty interval 36.6–38.9) of 25-year-olds would be expected to develop diabetes at some time throughout their life. On average, a 25-year-old Australian will live a further 56 years, 48 of these free of diabetes. On average, a 45-year-old person with diabetes can expect to live 6 years less than a person free of diabetes. The prevalence of diabetes is projected to rise from 7.6% in 2000 to 11.4% by 2025.

Conclusions/interpretation

If we maintain current diabetes incidence rates, more than a third of individuals will develop diabetes within their lifetime and in Australia there will an additional 1 million cases of diabetes by the year 2025.
Literature
1.
go back to reference Sicree RA, Shaw JE, Zimmet PZ (2006) Diabetes and impaired glucose tolerance. In: Gan D (ed) Diabetes Atlas, 3rd Edition. International Diabetes Federation, Belgium, pp 15–105 Sicree RA, Shaw JE, Zimmet PZ (2006) Diabetes and impaired glucose tolerance. In: Gan D (ed) Diabetes Atlas, 3rd Edition. International Diabetes Federation, Belgium, pp 15–105
2.
go back to reference Dunstan DW, Zimmet PZ, Welborn TA et al (2002) The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 25:829–834PubMedCrossRef Dunstan DW, Zimmet PZ, Welborn TA et al (2002) The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 25:829–834PubMedCrossRef
3.
go back to reference Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF (2003) Lifetime risk for diabetes mellitus in the United States. JAMA 290:1884–1890PubMedCrossRef Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF (2003) Lifetime risk for diabetes mellitus in the United States. JAMA 290:1884–1890PubMedCrossRef
4.
go back to reference Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ (2006) Impact of recent increase in incidence on future diabetes burden: US, 2005–2050. Diabetes Care 29:2114–2116PubMedCrossRef Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ (2006) Impact of recent increase in incidence on future diabetes burden: US, 2005–2050. Diabetes Care 29:2114–2116PubMedCrossRef
5.
go back to reference Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053PubMedCrossRef Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053PubMedCrossRef
6.
go back to reference Dunstan DW, Zimmet PZ, Welborn TA et al (2002) The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)—methods and response rates. Diabetes Res Clin Pract 57:119–129PubMedCrossRef Dunstan DW, Zimmet PZ, Welborn TA et al (2002) The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)—methods and response rates. Diabetes Res Clin Pract 57:119–129PubMedCrossRef
7.
go back to reference Magliano DJ, Barr EL, Zimmet PZ et al (2008) Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 31:267–272PubMedCrossRef Magliano DJ, Barr EL, Zimmet PZ et al (2008) Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 31:267–272PubMedCrossRef
8.
go back to reference World Health Organization (1999) Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications; Part 1: Diagnosis and Classification of Diabetes Mellitus. World Health Organization, Geneva World Health Organization (1999) Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications; Part 1: Diagnosis and Classification of Diabetes Mellitus. World Health Organization, Geneva
9.
go back to reference Barr EL, Zimmet PZ, Welborn TA et al (2007) Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 116:151–157PubMedCrossRef Barr EL, Zimmet PZ, Welborn TA et al (2007) Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 116:151–157PubMedCrossRef
11.
go back to reference Nusselder WJ, Peeters A (2006) Successful aging: measuring the years lived with functional loss. J Epidemiol Community Health 60:448–455PubMedCrossRef Nusselder WJ, Peeters A (2006) Successful aging: measuring the years lived with functional loss. J Epidemiol Community Health 60:448–455PubMedCrossRef
12.
go back to reference Schoen R (1988) Modelling Multi-group Populations. Plenum Press, New York Schoen R (1988) Modelling Multi-group Populations. Plenum Press, New York
13.
go back to reference Australian Bureau of Statistics (2000) Population by Age and Sex, Australia. Companion Data. Australian Bureau of Statistics, Canberra Australian Bureau of Statistics (2000) Population by Age and Sex, Australia. Companion Data. Australian Bureau of Statistics, Canberra
14.
go back to reference Australian Bureau of Statistics (2006) Population Projections, Australia, 2004–2101. Australian Bureau of Statistics, Canberra Australian Bureau of Statistics (2006) Population Projections, Australia, 2004–2101. Australian Bureau of Statistics, Canberra
16.
go back to reference Lipscombe LL, Hux JE (2007) Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995–2005: a population-based study. Lancet 369:750–756PubMedCrossRef Lipscombe LL, Hux JE (2007) Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995–2005: a population-based study. Lancet 369:750–756PubMedCrossRef
17.
go back to reference Fox CS, Pencina MJ, Meigs JB, Vasan RS, Levitzky YS, D’Agostino RB Sr (2006) Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study. Circulation 113:2914–2918PubMedCrossRef Fox CS, Pencina MJ, Meigs JB, Vasan RS, Levitzky YS, D’Agostino RB Sr (2006) Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study. Circulation 113:2914–2918PubMedCrossRef
18.
19.
go back to reference Narayan KM, Boyle JP, Thompson TJ, Gregg EW, Williamson DF (2007) Effect of BMI on lifetime risk for diabetes in the US. Diabetes Care 30:1562–1566PubMedCrossRef Narayan KM, Boyle JP, Thompson TJ, Gregg EW, Williamson DF (2007) Effect of BMI on lifetime risk for diabetes in the US. Diabetes Care 30:1562–1566PubMedCrossRef
20.
go back to reference Burke JP, Williams K, Gaskill SP, Hazuda HP, Haffner SM, Stern MP (1999) Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study. Arch Intern Med 159:1450–1456PubMedCrossRef Burke JP, Williams K, Gaskill SP, Hazuda HP, Haffner SM, Stern MP (1999) Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study. Arch Intern Med 159:1450–1456PubMedCrossRef
21.
go back to reference Knowler WC, Bennett PH, Hamman RF, Miller M (1978) Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 108:497–505PubMed Knowler WC, Bennett PH, Hamman RF, Miller M (1978) Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 108:497–505PubMed
22.
go back to reference Bonora E, Kiechl S, Willeit J et al (2004) Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study. Diabetes 53:1782–1789PubMedCrossRef Bonora E, Kiechl S, Willeit J et al (2004) Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study. Diabetes 53:1782–1789PubMedCrossRef
23.
go back to reference Valdes S, Botas P, Delgado E, Alvarez F, Cadorniga FD (2007) Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study. Diabetes Care 30:2258–2263PubMedCrossRef Valdes S, Botas P, Delgado E, Alvarez F, Cadorniga FD (2007) Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study. Diabetes Care 30:2258–2263PubMedCrossRef
24.
go back to reference Cugati S, Wang JJ, Rochtchina E, Mitchell P (2007) Ten-year incidence of diabetes in older Australians: the Blue Mountains Eye Study. Med J Aust 186:131–135PubMed Cugati S, Wang JJ, Rochtchina E, Mitchell P (2007) Ten-year incidence of diabetes in older Australians: the Blue Mountains Eye Study. Med J Aust 186:131–135PubMed
25.
go back to reference Mooy JM, Grootenhuis PA, de Vries H et al (1996) Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia 39:298–305PubMedCrossRef Mooy JM, Grootenhuis PA, de Vries H et al (1996) Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia 39:298–305PubMedCrossRef
26.
go back to reference de Vegt F, Dekker JM, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ (2000) Similar 9-year mortality risks and reproducibility for the World Health Organization and American Diabetes Association glucose tolerance categories: the Hoorn Study. Diabetes Care 23:40–44PubMedCrossRef de Vegt F, Dekker JM, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ (2000) Similar 9-year mortality risks and reproducibility for the World Health Organization and American Diabetes Association glucose tolerance categories: the Hoorn Study. Diabetes Care 23:40–44PubMedCrossRef
27.
go back to reference Peeters A, Mamun AA, Willekens F, Bonneux L (2002) A cardiovascular life history. A life course analysis of the original Framingham Heart Study cohort. Eur Heart J 23:458–466PubMedCrossRef Peeters A, Mamun AA, Willekens F, Bonneux L (2002) A cardiovascular life history. A life course analysis of the original Framingham Heart Study cohort. Eur Heart J 23:458–466PubMedCrossRef
29.
go back to reference Ward JE, Hughes AM, Hirst GH, Winchester L (1997) Men’s estimates of prostate cancer risk and self-reported rates of screening. Med J Aust 167:250–253PubMed Ward JE, Hughes AM, Hirst GH, Winchester L (1997) Men’s estimates of prostate cancer risk and self-reported rates of screening. Med J Aust 167:250–253PubMed
Metadata
Title
Lifetime risk and projected population prevalence of diabetes
Authors
D. J. Magliano
J. E. Shaw
S. M. Shortreed
W. J. Nusselder
D. Liew
E. L. M. Barr
P. Z. Zimmet
A. Peeters
Publication date
01-12-2008
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 12/2008
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-008-1150-5

Other articles of this Issue 12/2008

Diabetologia 12/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine